News

Harvest Health Posts Q4 2019 Earnings Miss – The Worst Luck With Acquisitions

Harvest Health (CNSX: HARV, OTCMKTS: HRVSF) has posted their results for Q4 2019. Revenue came in at $37.8M which missed analysts’ estimates of $39.45M Adjusted EBITDA came in -$6.8M which missed estimates of -$3.23M The company posted the following highlights for the Full Fiscal 2019 year: New capital raised during 2019 included short-term debt, unsecured […]

Read More
News

Trulieve Posts Q4 2019 Earnings Beat – The Ultimate Value Cannabis Stock?

Trulieve Cannabis Corp (CNSX: TRUL , OTCMKTS: TCNNF) has posted their results for Q4 2019. Revenue came in at $79.7M which beat analysts’ estimates of $79.54M Adjusted EBITDA came in $45.0M which beat estimates of $32.19M Comparing Trulieve’s stock performance to its peers, we see that although the stock price has decline by over 30% […]

Read More
News

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 12th, 2020)

Bottom Line: With much of the global population stuck indoors, we are already seeing indications of spiking consumption and demand for pot, booze and smokes. Historically the stocks in these sectors outperform the market during recessions, will this time be any different?   Read more» Bottom Line: European Union Good Manufacturing Practice (EU-GMP) certification audits […]

Read More
News

What Does Aurora Cannabis’ 12-for-1 Reverse Stock Split Mean for You

Aurora Cannabis (TSE:ACB, NYSE:ACB) has announced a 12-to-1 consolidation (otherwise known as a reverse split) of its common shares effective on or around May 11, 2020. This consolidation will see its 1,313,494,990 shares consolidated down to 109,457,915 shares. The stock price will go from $0.74 as we write this to $8.76 per share, but a […]

Read More
News

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 18th, 2020)

Bottom Line: In this edition of The Post Roll, we review all the big earnings this week. What went wrong, what went right and what the numbers mean for the stock prices. Read more» Bottom Line: Grizzle sat down for an exclusive interview with Kim Rivers, the CEO of cannabis market leader Trulieve. Check out […]

Read More
News

Organigram Announces $49M At-The-Market Equity Program

Earlier, we reported on Organigram’s (TSE:OGI, NASDAQ:OGI) Q2 2020 earnings which raised some concerns about the company’s cash position. Now, as we feared and warned investors about earlier, the company has announced today that it is doing a at-the-market equity raise program valued at $49M. In particular, the company is burning through around $46M every […]

Read More
News

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 25th, 2020)

Bottom Line: We warned investors last week that Organigram had a cash problem. Now in a release that  should have surprised no one they are issuing stock to continue funding their business. The share count will go up 15% if Organigram uses the program in full. Read more» Bottom Line: Yet another producer cutting prices […]

Read More
Back To Top